28 October 2009
EDGE™ Safety Hypodermic Syringes for Government flu preparedness effort
Smiths Medical today announces a contract award from the U.S. Department of Health and Human Services (HHS) for safety hypodermic syringes that could reach $10 million as part of the Government's national flu pandemic preparedness efforts.
Stuart Morris-Hipkins, president of Smiths Medical North America, said: "Expert estimates suggest that the H1N1 flu could affect half of all Americans, including groups like healthy young adults previously thought to be at low risk. We are proud to support the government's efforts to protect as many people as possible from H1N1 flu."
In addition to supplying important safety products, Smiths Medical staff will be available should an emergency need arise for additional products. The company, part of the global technology business Smiths Group, has also set aside dedicated warehouse space for HHS to help ensure that products are available whenever needed.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths honoured at the London Stock Exchange
Read our latest company news as Smiths is honoured at the London Stock Exchange.
Find out more
Smiths appoints new independent Non-executive Director
Read our latest company news as the Board of Smiths is pleased to announce the appointment of Laurence Mulliez as an independent Non-executive Director, with effect from 1 September 2026.
Find out more
Smiths Group plc – Q3 trading update
Find out more
